Affiliations 

  • 1 Department of Pharmacy Practice, Faculty of Pharmacy, International Islamic University Malaysia, Kuantan, Pahang, Malaysia; Quality Use of Medicines Research Group, Faculty of Pharmacy, International Islamic University Malaysia, Kuantan, Pahang, Malaysia. Electronic address: drmelnaem@gmail.com
  • 2 School of Pharmacy, University of Birmingham, Edgbaston, Birmingham, UK. Electronic address: e.cheema@bham.ac.uk
Res Social Adm Pharm, 2021 01;17(1):1938-1941.
PMID: 32507575 DOI: 10.1016/j.sapharm.2020.05.030

Abstract

The current pandemic of the COVID-19 infection, coupled with the increased global burden of diabetes, has imposed significant challenges to the healthcare providers in providing effective and sustained care to patients with diabetes during the ongoing pandemic. It is, therefore, important for healthcare providers to understand and follow the recommended changes in the delivery of care, lifestyle modifications, and pharmacotherapy to ensure optimal care to the patients during and post-pandemic era. This commentary aims to discuss the impact of COVID-19 on diabetes care and the important considerations for pharmacists during this pandemic.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.